Procter & Gamble (PG) Gains After Moving Up Earnings
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Procter & Gamble (PG) PT Lowered to $75 at JPMorgan
April 20, 2018 8:23 AM EDTJPMorgan lowered its price target on Procter & Gamble (NYSE: PG) to $75.00 (from $80.00) while maintaining a Neutral rating following the company's 3Q earnings report. PGs reported organic sales growth of +1% was a 100bps sequential deceleration on reported figures from 2Q. Management now expects... More
Procter & Gamble (PG) Acquires Merck KGaA's Consumer Health Unit for Approx. $4.2B
April 19, 2018 6:01 AM EDTThe Procter & Gamble Company (NYSE: PG) today announced it has signed an agreement to acquire the Consumer Health business of Merck KGaA, Darmstadt, Germany, for a purchase price of approximately 3.4 billion euro.
This acquisition enables P&G to expand its successful consumer health care business by adding a fast-growing portfolio of differentiated, physician-supported brands across a broad geographic footprint. It also provides P&G with strong health care commercial and supply capabilities, deep technical mastery... More
